Biopharmaceuticals for Rare and Chronic Diseases
The Rise of Biosimilars
The emergence of biosimilars is a transformative trend within the Biopharmaceuticals Market. Biosimilars are highly similar, but not identical, to a reference biopharmaceutical and are approved through a rigorous regulatory process. Their introduction is a key factor in market evolution, as discussed in reports like the one on the Biopharmaceuticals Market. Biosimilars offer a more affordable alternative to expensive branded biologics, which can improve patient access and drive down healthcare costs. This article could prompt a discussion on the regulatory pathways for biosimilar approval, the price competition they introduce, and their potential to disrupt the market.
1 View